- About Us
- Press Releases
- 2010
- SCIEX Software Application Advances Disease Research, Drug Discovery and Biomarker Research
SCIEX, a global leader in life science analytical technologies, today announced the launch of the first mass-spectrometry-based software application specifically designed to advance the study of lipidomics.
SCIEX, a global leader in life science analytical technologies, today announced the launch of the first mass-spectrometry-based software application specifically designed to advance the study of lipidomics. LipidViewTM Software is the first commercially available software using the analytical accuracy and speed of mass spectrometry to characterize molecules in studies of lipidomics, which is an emerging field of systems biology that is being applied for disease research, drug discovery and biomarker research for potential use in clinical settings.
Researchers are increasingly exploring the range of functions that lipids have within the human body, including energy storage, cell membrane structure and hormone signaling. LipidView Software responds to the need of lipidomics researchers who have been seeking tools focused specifically on this new discipline to provide more accurate and faster results. LipidView Software is an automated data processing tool that enables researchers to more effectively identify and quantify lipids from complex samples, providing standardized information from a catalog of more than 40 lipid classes and 23,000 possible lipid species.
Among the organizations adopting LipidView Software is Zora Biosciences, a leader in providing advanced lipidomics services to the pharmaceutical industry. Researchers at Zora Biosciences are supporting drug discovery projects by delivering critical information about lipids that can be used to help develop more effective drugs. They are using LipidView Software to significantly accelerate data processing of mass spectrometry-based analysis for lipid profiling as a means to better understand complex medical conditions, including diabetes and obesity, in efforts to develop better drugs and discover useful lipid biomarkers.
Highlights
Quotes
Kim Ekroos, Ph.D., Head of Bioanalytics, Zora Biosciences
"The ability to identify new drug targets and better understand diseases at the lipid level will ultimately improve drug discovery and help create more effective treatments. LipidView Software gives us the ability to process massive amounts of mass spectrometry data in an automated way that was previously unavailable. This expands our analytical capabilities, accelerates our processes and enables us to generate higher quality information, which not only provides us with more confidence in the results, but also our clients in the pharmaceutical industry."
Laura Lauman, President, SCIEX
"SCIEX continues to innovate to help advance life science research by developing new software tools that apply the power of mass spectrometry to a broader range of applications. LipidView Software is another example of how SCIEX delivers software that manages complete workflow solutions for drug discovery and biomarker research. This new tool will help researchers expand the study of lipids as part of an emerging field within systems biology."
Media Resources
The Lipid Library
Lipidomics Gateway for lipid biology
SCIEX technology portfolio
Social Media Tags
Lipidomics, drug discovery, biofuels, personalized medicine, biomarkers, lipids, LipidView, QTRAP.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit sciex.com
SCIEX social: @SCIEXnews, LinkedIn, and Facebook.
AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.
For research use only. Not for use in diagnostic procedures.
Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
lulu.vanzandt@sciex.com
+1 (508) 383-7163
M: +1 (508) 782-9484